1Goldberg AI , Dunlay MC , Sweet CS. Safety and tolerability of losartan potassium : an angiotensin Ⅱ receptro antagonist, compared with hydrochlorothiazide aienolol felodipine and angiotensin2converting enzyme inhibitors for the treatment of systemic hypertension[J]. Am J Cardio ,1995 ,75 (12) :793.
2Van Rijinsoeverrea , Wilma J , Kwee zuiderwijk M. Angioneurotic edema attributed to the use of losartan[J]. Arch Intern Med , 1998 ,158 (12) :2063.
3Schwarzbeck A,Wittenmeier KW,Hallfritzsch U. Anaemia in dialy sis patients as a side effect of sartanes[J]. Lancet, 1998 , 352 (9124) :286.
4Horn S, Holzer H, Horina J. Losartan and renal transplantation [J].Lancet,1998 ,351 (9096) :111.
5Heeringa M ,Eugene P. Reversible dysgeusia attributed to losartan [J]. Annals of Internal medicine ,1998 ,129 (1) :72.
6Viraben R, Lamaut L, Brousset P. Losartan-associted a typical cutaneous lymphoid hyperplasia [ J]. Lancet, 1997, 350 (9088) : 1366.
7Kaufam J, Casanova JE, Riendl P, et al. Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors[J]. Chest. 1989, 95(3):544-8.
